Loading…

Loading grant details…

Active NON-SBIR/STTR RPGS NIH (US)

Core A: Curation and Statistical Analysis Core


Funder NATIONAL CANCER INSTITUTE
Recipient Organization Sloan-Kettering Inst Can Research
Country United States
Start Date Sep 03, 2024
End Date Aug 31, 2029
Duration 1,823 days
Number of Grantees 1
Roles Principal Investigator
Data Source NIH (US)
Grant ID 10768979
Grant Description

CORE A ABSTRACT Curation and Statistical Analysis Core Core Director: Kathy Panageas (MSK) The Curation and Statistical Analysis Core will be co-led by Drs. Katherine Panageas and Deb Schrag, who have a long-standing role in the AACR GENIE PRISSMM data curation efforts to date. The PRISSMM framework includes data collection with respect to: Pathology; Radiology; Imaging; Signs and Symptoms; tumor

Markers; and Medical oncologist assessments. The phenomic, therapeutic, and oncologic outcome data are curated from the electronic health record (EHR) and other institutional data sources according to the patient- and cancer-centric PRISSMM framework for determination of real-world cancer outcomes. PRISSMM utilizes

a cancer-agnostic curation model that standardizes key components of outcome ascertainment in oncology based on existing data standards. Specifically, all pathology reports, all radiology reports for imaging studies other than plain x-rays and ultrasounds, and one medical oncologist note per month are curated. Aim 1 of the

Core will be to develop and maintain data standards to support consistent and transparent abstraction of clinical data from electronic health records. Curation initiatives require assessment of different components of data quality throughout the curation process. Multi-pronged QA processes will be implemented and evaluated as

part of the Core to address feasibility, accuracy, and reproducibility. In order to assess whether real world progression-free survival (PFS) determined using the PRISSMM data model (based on imaging, PFS-I or based on medical oncologist assessment PFS-M) approximates PFS based on RECIST, the gold standard for

defining disease progression in the clinical trial setting, radiologist measurements will be performed and interpretations will be compiled with PRISSMM outcomes. The statistical aspects of the design and analysis of the clinico-genomic analyses in our proposal share many common elements as they relate to analysis of

complex genomic data, nuances of PRISSMM data model and patient populations. Aim 2 of the Core will be to provide methodologic and biostatistics support and collaboration for individual observational data analysis. Dedicated shared resources for expert biostatistics and genomics analyses for our P01 program will ensure

the necessary rigor and reproducibility critical to our proposed studies.

All Grantees

Sloan-Kettering Inst Can Research

Advertisement
Discover thousands of grant opportunities
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant